Improving Neonatal Hip Screening With Artificial Intelligence

The goal of this trial is to pilot a portable ultrasound device that uses artificial intelligence to screen for hip dysplasia. Researchers will gather data to understand the feasibility of performing a larger trial in birthing hospitals. It will also seek to collect initial data on how well the scan compares to the standard hip screening performed soon after birth. Participants will: * Have the portable ultrasound performed on their baby before they are discharged from hospital * Have a diagnostic ultrasound performed on their baby at 6-weeks of age * Complete a short questionnaire about the experience of having the measurement performed on their baby

Inclusion Criteria: 1. Enrolled in the Victorian Hip Dysplasia Registry (VicHip) study 2. Infant born at term (≥37 weeks gestation) 3. Infant and caregiver admitted to the post-natal ward 4. Caregivers indicate they are willing to attend a 6-week ultrasound 5. Caregivers can provide a signed and dated informed consent form and is a legally acceptable representative capable of understanding the informed consent document and providing consent on the infant's behalf. Exclusion Criteria: 1. Any known congenital anomalies in the infant precluding examination of the hips 2. Any known congenital neuromuscular conditions in the infant